Algorhythm (NASDAQ:RIME) executives used the company’s full-year 2025 earnings call to emphasize accelerating commercial traction for SemiCab, its AI-powered logistics platform, while CFO and General Counsel Alex Andre detailed results reshaped by the acquisition of SemiCab’s India operations and the sale of a legacy business. Management highlights SemiCab’s goal: reducing empty miles CEO Gary Atkinson […]

Bassett Furniture Industries (NASDAQ:BSET) reported a softer start to fiscal 2026 as winter weather disruptions and tariff-related margin pressure weighed on first-quarter results, even as management highlighted improving order momentum late in the quarter and outlined several growth initiatives. Quarterly slowdown followed early strength Chairman and CEO Rob Spilman said the company began the quarter […]

Franklin Covey (NYSE:FC) executives said the company’s fiscal second quarter 2026 results showed continued momentum from its go-to-market changes in Enterprise North America, with invoiced amounts rising and deferred revenue building, while the Education Division delivered double-digit revenue growth. Management highlights: invoice growth and expanding deferred revenue CEO Paul Walker said the company was “pleased […]

goeasy (TSE:GSY) executives used the company’s fourth-quarter 2025 earnings call to address a sharp deterioration in credit performance at its LendCare business, outline steps taken since disclosing the issue in March, and provide near-term guidance that reflects elevated charge-offs and a smaller loan book in early 2026. Patrick Ens, on his first call as chief […]

TruBridge (NASDAQ:TBRG) executives highlighted modest revenue growth expectations for 2026, continued margin expansion, and ongoing efforts to strengthen financial reporting during the company’s full-year and fourth-quarter earnings call. Management also discussed a strategic review process and described product, operational, and artificial intelligence initiatives aimed at improving performance and customer outcomes. 10-K filing, audit adjustments, and […]

Intermap Technologies (TSE:IMP) executives said delays in follow-on awards tied to Indonesia and U.S. government programs drove a sharp year-over-year revenue decline in 2025, even as the company reported strong growth in recurring commercial revenue and continued investment in technology and capacity. 2025 results shaped by timing of government awards Chairman and CEO Patrick Blott […]

Volatus Aerospace executives said fiscal 2025 marked a “transformational” year as the company worked to build what it described as an integrated aerospace and defense platform spanning drones, piloted aviation, manufacturing, software, and training. During the company’s earnings call, CEO Glenn Lynch and CFO Abhinav Singhvi detailed a year of strong revenue growth, increased defense […]

Nuvve (NASDAQ:NVVE) executives used the company’s fourth-quarter and full-year 2025 earnings call to emphasize a strategic pivot away from vehicle-to-grid (V2G) deployments toward stationary battery storage, while also detailing quarterly results that included a sizable one-time inventory impairment tied to discontinued charger hardware. Management highlights pivot to stationary storage Chief Executive Officer Gregory Poilasne described […]

MSC Industrial Direct (NYSE:MSM) executives said fiscal 2026 second-quarter results reflected stronger-than-expected margin performance and disciplined cost management, but sales growth fell short of the company’s outlook as organizational changes in the field created near-term disruption. Management also pointed to early signs of improving industrial demand and guided to faster sales growth in the fiscal […]

Xtant Medical (NYSEAMERICAN:XTNT) reported fourth-quarter and full-year 2025 results highlighting modest quarterly revenue growth, improved profitability, and a sharper strategic focus following the sale of non-core assets to Companion Spine. Fourth-quarter results show revenue growth and continued profitability President and CEO Sean Browne said the company delivered “solid financial performance” in the fourth quarter, with […]

NORMA Group (ETR:NOEJ) executives said the company finished a “very tough and challenging” 2025 while completing the divestment of its Water Management business, a transaction that Chief Executive Officer Birgit Seeger called a “milestone” that provides the foundation for a strategic reset in 2026 and a longer-term repositioning as an “industrial powerhouse for Connecting Solutions.” […]

Inventiva (NASDAQ:IVA) used its full-year 2025 results call to outline a company-wide focus on advancing its lead candidate lanifibranor toward a potential approval in metabolic dysfunction-associated steatohepatitis (MASH), while also detailing a strengthened cash position and several strategic organizational changes. Company narrows focus to lanifibranor and NATiV3 Chief Executive Officer Andrew Obenshain said that since […]

RH (NYSE:RH) executives used the company’s latest earnings call to emphasize what Chairman and CEO Gary Friedman described as a period of “clutter,” driven by tariffs, global conflict and what he called “the most dire housing market in decades,” while arguing that the company is using the environment to position the brand for longer-term growth. […]

Executives at eXoZymes (NASDAQ:EXOZ) used the company’s latest investor call to outline how management is prioritizing a narrower set of commercial opportunities, led by its NCT program and a cannabinoid pipeline, while preparing for a new financing round and continuing to develop its cell-free biomanufacturing platform. Management says 2025 marked a strategic refocus toward asset […]

RH (NYSE:RH) executives used the company’s latest earnings call to emphasize what Chairman and CEO Gary Friedman described as a period of “clutter,” driven by tariffs, global conflict and what he called “the most dire housing market in decades,” while arguing that the company is using the environment to position the brand for longer-term growth. […]

Executives at eXoZymes (NASDAQ:EXOZ) used the company’s latest investor call to outline how management is prioritizing a narrower set of commercial opportunities, led by its NCT program and a cannabinoid pipeline, while preparing for a new financing round and continuing to develop its cell-free biomanufacturing platform. Management says 2025 marked a strategic refocus toward asset […]

GEN Restaurant Group (NASDAQ:GENK) executives said the company faced a “very challenging environment” in the fourth quarter of 2025, pointing to pressure on customer traffic and higher costs, while outlining a strategic pivot that emphasizes operational initiatives and a rapidly expanding consumer packaged goods (CPG) business. Management cites traffic pressures and weaker same-store sales Chairman […]

Co-Diagnostics (NASDAQ:CODX) executives highlighted progress on international expansion, clinical development plans, and financing flexibility while reviewing a year of lower revenue and a wider GAAP net loss, driven in part by a large non-cash impairment charge. On the company’s fourth-quarter and full-year 2025 earnings call, Chief Executive Officer Dwight Egan said the period was “one […]

Rekor Systems (NASDAQ:REKR) detailed improved margins and reduced losses in 2025 as management said it shifted the company from a development-heavy posture to a more disciplined, customer-focused operating model. 2025 results: revenue growth, higher margins, and lower losses CFO Joseph Nalepa said Rekor generated $48.5 million in revenue for the year ended Dec. 31, 2025, […]

XBP Global (NASDAQ:XBP) used its fourth-quarter 2025 earnings call to frame 2025 as a transition year following its late-July acquisition of Exela Technologies BPA, with management emphasizing platform integration, an AI-led operating model, and renewed investment in sales. CEO Andrej Jonovic and CFO Dejan Avramovic focused their prepared remarks on pro forma results intended to […]

nCino (NASDAQ:NCNO) executives highlighted fiscal 2026 outperformance versus guidance, accelerating annual contract value (ACV) growth, and what they described as increasing customer adoption of the company’s AI capabilities during the company’s fourth-quarter earnings call. AI adoption and platform positioning Chief Executive Officer Sean Desmond said nCino “exceeded our financial guidance across every key metric” in […]

BUDA (NYSEAMERICAN:BUDA) executives highlighted profitable growth, a debt-free balance sheet, and early momentum in 2026 during the company’s fourth-quarter and full-year 2025 earnings call—its first as a public company following an IPO completed in January. IPO milestone and “ultra-fresh” positioning Chief Executive Officer Horatio Lonsdale-Hands said the January IPO was “an important milestone,” adding that […]

authID (NASDAQ:AUID) executives used the company’s fourth-quarter and full-year 2025 earnings call to highlight what CEO Rhon Daguro described as rising enterprise urgency around identity security, driven by “the rise of deepfakes” and “rogue AI agents accessing systems without human accountability.” Management said that shift has increased inbound interest from large organizations seeking privacy-preserving biometric […]

Omeros (NASDAQ:OMER) executives highlighted two “major successes” in the fourth quarter of 2025 that they said marked a turning point for the company: closing a $240 million upfront asset sale and license deal with Novo Nordisk for the phase III-ready complement asset zaltenibart, and receiving FDA approval for narsoplimab—now marketed as YARTEMLEA—as the first approved […]

Nuvve (NASDAQ:NVVE) executives used the company’s fourth-quarter and full-year 2025 earnings call to emphasize a strategic pivot away from vehicle-to-grid (V2G) deployments toward stationary battery storage, while also detailing quarterly results that included a sizable one-time inventory impairment tied to discontinued charger hardware. Management highlights pivot to stationary storage Chief Executive Officer Gregory Poilasne described […]

Imunon (NASDAQ:IMNN) executives used the company’s fourth quarter and full-year 2025 earnings call to emphasize progress in the development of its IL-12 immunotherapy candidate IMNN-001 for newly diagnosed advanced ovarian cancer, while also outlining funding priorities and updated financial results. OVATION 2 data show expanded overall survival benefit President and CEO Dr. Stacy Lindborg highlighted […]

FactSet Research Systems (NYSE:FDS) reported second-quarter fiscal 2026 results that management said reflected accelerating growth across geographies and client types, alongside ongoing investment in technology and productivity initiatives tied to artificial intelligence. On the company’s earnings call, CEO Sanoke Viswanathan said annual subscription value (ASV) growth accelerated for the fourth consecutive quarter. Organic ASV increased […]

T1 Energy executives used the company’s fourth-quarter and full-year 2025 earnings call to outline plans for completing what CEO Dan Barcelo called the company’s “vertically integrated domestic solar chain” in the U.S., while detailing recent capital raises, progress at its Dallas module plant, and construction milestones for its Austin solar cell facility. Strategic focus shifts […]

AirJoule Technologies (NASDAQ:AIRJ) used its fourth-quarter and full-year 2025 earnings call to outline how it plans to shift from field validation and product development into commercialization activities in 2026, while highlighting what CEO Matt Jore described as a rising need for “water resilience.” Management frames opportunity around water resilience Jore opened the call by pointing […]

NextPlat (NASDAQ:NXPL) executives used the company’s year-end 2025 results conference call to outline progress in a business turnaround effort, point to early 2026 indicators of margin improvement, and explain a recently announced reverse stock split undertaken to maintain its Nasdaq listing. Management frames 2025 as a turning point Chief Executive Officer David Phipps said the […]

Meridian Holdings reported record revenue for the fourth quarter and full-year 2025, while posting a sharply wider GAAP net loss in the quarter driven largely by a non-cash impairment tied to a sustained decline in its share price. Fourth-quarter revenue rises; net loss widens on impairment William Scott, Interim Chief Executive Officer and President of […]

AIRO Group (NASDAQ:AIRO) reported fourth-quarter and full-year 2025 results that management described as a “defining year,” highlighted by a sharp rebound in quarterly revenue tied to delivery timing, continued drone-led demand, and expanded investment in U.S. manufacturing and future unmanned platforms. Management frames 2025 as execution year and strategic pivot Executive Chairman Dr. Chirinjeev Kathuria […]

Solésence, the parent company of Nanophase Technologies (OTCMKTS:NANX), used its fourth quarter and full-year 2025 earnings call to outline a new operational and growth framework dubbed “Transform and Transcend”, while also addressing margin pressure that accompanied rapid revenue growth in 2025. Fourth quarter results: higher margin, return to profit Chief Financial Officer Laura Riffner reported […]

Bitfarms (NASDAQ:BITF) used its fiscal 2025 earnings call to outline a significant strategic shift away from Bitcoin mining and toward developing high-performance computing (HPC) and artificial intelligence (AI) data center infrastructure in North America, a transition Chief Executive Officer Ben Gagnon described as a “deliberate and consequential transformation.” Gagnon said the company has moved to […]

Phreesia (NYSE:PHR) executives said fiscal 2026 marked a major shift in the company’s financial profile, highlighted by record profitability metrics, while also warning that more variable pharmaceutical marketing budgets are pressuring visibility in its Network Solutions business and lowering the company’s fiscal 2027 revenue outlook. Fiscal 2026 milestones: profitability and cash flow Chief Executive Officer […]

Standard Lithium (NYSEAMERICAN:SLI) used its fourth-quarter 2025 earnings call to outline progress toward a final investment decision (FID) for its Southwest Arkansas (SWA) project while also highlighting early-stage momentum in East Texas. Management emphasized recent technical, regulatory, commercial, and financing milestones, alongside a quarterly net loss that included a sizable impairment tied to the company’s […]

Lulu’s Fashion Lounge (NASDAQ:LVLU) executives on the company’s fourth quarter and fiscal 2025 earnings call emphasized progress on profitability and cost structure, continued strength in event-driven categories, and accelerating wholesale expansion, while acknowledging ongoing work to reposition casual apparel and footwear. Management highlights “transformational” year focused on efficiency and margins CEO Crystal Landsem said 2025 […]

Intellinetics (NYSEAMERICAN:INLX) reported modest fourth-quarter revenue growth and improved gross margin in its fourth quarter and full-year 2025 earnings call, while highlighting a full-year revenue decline tied to lower professional services activity and increased investment spending. The company also outlined its focus on execution and accelerating SaaS growth under newly appointed President and CEO Alison […]

Spruce Power (NYSE:SPRU) reported fourth-quarter and full-year 2025 results that management characterized as a “breakout year,” citing higher revenue, expanding margins, improved cash generation, and continued debt paydown. On the company’s earnings call, Chief Executive Officer Chris Hayes and Chief Financial Officer Thomas Cimino also addressed an upcoming going concern disclosure tied to the timing […]

INmune Bio (NASDAQ:INMB) management used its fourth quarter and full-year 2025 earnings call to outline progress across its three development platforms and to reiterate a 2026 focus on regulatory execution, late-stage trial planning, and capital efficiency. CORDStrom advances toward regulatory filings in RDEB Chief Executive Officer and Co-Founder David Moss said 2025 marked a “pivotal […]

Beeline (NASDAQ:BLNE) executives used the company’s fourth-quarter 2025 earnings call to highlight rapid revenue growth, improving unit economics in its core mortgage operation, and early momentum in a new fee-based home equity transaction product the company calls BeelineEquity. Management frames 2025 as a “transformational year” Chief Executive Officer Nick Liuzza said 2025 was “a transformational […]

Nano Labs (NASDAQ:NA) executives used the company’s second-half 2025 earnings call to outline a strategy centered on expanding a BNB-focused crypto asset reserve while advancing new AI agent-related hardware and ecosystem initiatives. Management highlights BNB reserve strategy Chairman and CEO Jianping Kong said the company views the broader Web3 environment as improving in 2025, citing […]

PDS Biotechnology (NASDAQ:PDSB) executives used the company’s fourth-quarter 2025 earnings call to highlight progress across its oncology pipeline, with a particular focus on a protocol amendment to its phase III VERSATILE-003 trial that adds progression-free survival (PFS) as an interim primary endpoint in HPV-16-positive recurrent and/or metastatic head and neck cancer. Management also reviewed early […]

SKYX Platforms (NASDAQ:SKYX) executives highlighted record quarterly and annual revenue in 2025 and outlined several product and commercialization initiatives they believe can support continued growth, despite what management described as a multiyear downturn in lighting, home décor, and new homebuilding markets. 2025 results: record revenue and improved gross margin President Steven Schmidt said the company […]

TMC the metals (NASDAQ:TMC) used its fourth-quarter 2025 corporate update call to outline a faster regulatory and development pathway built around the U.S. permitting regime for deep seabed minerals, while also detailing plans for potential onshore nodule processing in Texas and discussing year-end liquidity and quarterly results. Shift to U.S. framework and permitting timeline Chairman […]

Journey Medical (NASDAQ:DERM) executives highlighted a “milestone” 2025 marked by the commercial launch of EMROSI, an internally developed oral treatment for the inflammatory lesions of rosacea, and pointed to improved profitability metrics as the product ramps. On the company’s full-year 2025 results and corporate update conference call, management said EMROSI generated $14.7 million in net […]

Precigen (NASDAQ:PGEN) executives said the company is seeing a rapid ramp in early commercial demand for PAPZIMEOS, its newly approved therapy for adult recurrent respiratory papillomatosis (RRP), as management discussed fourth-quarter and full-year 2025 results and provided a near-term update on first-quarter 2026 sales trends. PAPZIMEOS launch ramps from partial Q4 to first full quarter […]

Yunji (NASDAQ:YJ) executives said the company made “steady and solid progress” in the second half of 2025, highlighting a sharp narrowing of losses, a continued emphasis on premium and health-focused private-label products, and ongoing efforts to shift the business toward a “product plus experience” model. Second-half revenue and loss trends Management reported total revenue of […]

Modiv Industrial (NYSE:MDV) discussed fourth-quarter and full-year 2025 results and provided an update on its portfolio repositioning and capital recycling plans during its earnings call. Management also addressed recent inbound interest in the company and outlined how it is thinking about dispositions and acquisitions amid a volatile interest rate and macro backdrop. Fourth-quarter results and […]

Health In Tech (NASDAQ:HIT) executives used the company’s fourth-quarter and full-year 2025 earnings call to highlight rapid top-line growth, continued distribution expansion, and product initiatives aimed at moving further upmarket in self-funded employer health insurance. 2025 described as a “pivotal” first year as a public company Chief Executive Officer Tim Johnson said 2025 marked the […]